Health Care/Hospital

WHO Plans to Increase Treatment Access for Victims of Rabies and Snake Bites

GENEVA, Jan. 10 /Xinhua-PRNewswire/ -- Although more than 12 million people each year are bitten by dogs or snakes, or stung by scorpions, the world's capacity to treat them is inadequate. Effective treatment for these conditions is critically dependent on therapeutic sera*, but this essential ...

2007-01-10 12:05 842

Organon Partners With HUYA to Identify and Develop Chinese Biopharmaceuticals

Collaboration Looks for Opportunities to Expand the Organon Biotech Research Programs and Facilitate Links With China's Biotech Industry OSS, Netherlands and SAN DIEGO, Jan. 9 /Xinhua-PRNewswire/ -- Organon, the human healthcare business of Akzo Nobel (Nasdaq: AKZOY), announced today that i...

2007-01-09 21:00 856

TaiGen Initiates Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)

TAIPEI, Taiwan, Jan. 8 /Xinhua-PRNewswire/ -- TaiGen Biotechnology Inc. announced today that the company has started enrollment of patients for the Phase II clinical trial of Nemonoxacin (TG-873870) for the treatment of adult community acquired pneumonia (CAP). The randomized, double-blind, c...

2007-01-08 21:30 696

China Health Holding Announces Acquisition of All of the Assets of Xi’An Meichen Pharmaceutical

LAS VEGAS, Jan. 8 /Xinhua-PRNewswire-FirstCall/ -- China Health Holding, Inc. (OTC Bulletin Board: CHHH), a development stage company with the goal of becoming a developer, manufacturer, marketer and distributor of pharmaceutical products and dietary supplements in China and worldwide, anno...

2007-01-08 23:08 793

GfK HealthCare Asia Concludes Prescription Drug Pilot

New Service Shows Complete Picture of Pharmaceutical Sales Force with the addition of prescription tracking SINGAPORE and HONG KONG /Xinhua-PRNewswire/ -- GfK HealthCare Asia has concluded two highly successful pilots for its Sales Force Effectiveness (SFE) program, a...

2007-01-08 13:30 961

sanofi pasteur Influenza Vaccine Production Tops 170 Million Doses in 2006

Record Production Capabilities Strengthen sanofi pasteur’s Global Leadership in the Fight Against Seasonal Influenza and Place the Company at the Forefront of Pandemic Readiness LYON, France and SWIFTWATER, Pa., Jan. 8 /Xinhua-PRNewswire/ -- sanofi pasteur, the vaccines business of the sano...

2007-01-08 09:54 821

New Chinese Policy to Benefit Global Pharmatech

JILIN, China, Jan. 4 /Xinhua-PRNewswire/ -- Global Pharmatech, Inc. (OTC Bulletin Board: GBLP.OB) a company that develops, manufactures and markets proprietary botanical drugs and dietary supplements, announced that the Chinese State Food and Drug Administration (SFDA), has...

2007-01-04 23:00 980

Dr Margaret Chan Takes Office as Director-General of the World Health Organization

Impact on Health of Women and People in Africa to Be Measure of Success GENEVA, Jan. 4 /Xinhua-PRNewswire/ -- Dr Margaret Chan of China today took office as Director-General of the World Health Organization (WHO) following her election in November. She pledged that her term of office and t...

2007-01-04 19:44 893

AIDS Healthcare Foundation Announces New AIDS Treatment & Training Partnership in Xinjiang Province, China

AIDS Healthcare Foundation Joins Together With China's Xinjiang Medical University to Roll-Out the 'AHF - Xinjiang Medical University-Affiliated Hospital HIV/AIDS Treatment & Training Initiative' Partnership Between US' Largest AIDS Group and Respected Chinese Institutions Seek to Create a 'Cen...

2007-01-04 22:30 809

Gerresheimer Group Acquires European Market Leader for Medical Plastic Systems

-- With the Wilden Group Gerresheimer is Also Market Leader for Plastic Systems -- Gerresheimer CEO Dr. Axel Herberg: 'A giant step in our growth strategy' DUSSELDORF, Germany, Jan. 3 /Xinhua-PRNewswire/ -- A key chapter is added to the growth story of the Ger...

2007-01-03 14:00 1051

Global Pharmatech Announces Results of Annual Shareholders' Meeting

JILIN, China, Dec. 27 /Xinhua-PRNewswire/ -- Global Pharmatech, Inc. (OTC Bulletin Board: GBLP; the "Company") a company that develops, manufactures and markets proprietary botanical drugs and dietary supplements, today announced the results of its annual shareholders' meeting. (Logo: h...

2006-12-27 21:30 873

US Patent Granted to ScinoPharm for the Production of SN-38

TAINAN, Taiwan, Dec. 20 /Xinhua-PRNewswire/ -- ScinoPharm has just been awarded an US patent that relates to the preparation of SN-38, a key intermediate in the synthesis of irinotecan. The US patent, No. 7,151,179, entitled "Process for the Preparation of 7-Alkyl-10-Hydroxy-20(S)- Campt...

2006-12-20 19:20 889

Winner Medical Group Reports Fourth Quarter and Year End Fiscal 2006 Results

SHENZHEN CITY, China, Dec. 20 /Xinhua-PRNewswire/ -- Winner Medical Group Inc. (OTC Bulletin Board: WMDG), today reported financial results for the fourth quarter and fiscal year ended September 30, 2006. Revenues for the fourth fiscal quarter were $16.64 million compared to $18.56 mil...

2006-12-20 05:01 899

BioVision 2007, the World Life Sciences Forum, Set to Tackle Some of Today’s Most Critical Health, Nutrition and Environmental Issues

-- The 5th edition of BioVision (March 11 - 14, 2007 in Lyon, France) will gather leading international experts on health, nutrition and environment issues to discuss, debate and agree actions for change. LYON, France, Dec. 20 /Xinhua-PRNewswire/ -- BioVision today confirmed its broad...

2006-12-20 18:52 877

MedImmune Strengthens Inflammatory Disease Pipeline Through Collaboration With BioWa

- Initial Focus on Monoclonal Antibody Targeting IL-5 Receptor in Phase 1 Trials with Asthma Patients - GAITHERSBURG, Md. and PRINCETON, N.J., Dec. 19 /Xinhua-PRNewswire/ -- MedImmune, Inc. (Nasdaq: MEDI) and BioWa, Inc. announced today that they have entered into a licensing and coll...

2006-12-19 19:00 1002

The Prestigious Scientific Journal Nature Recognizes the Scientific Work Carried out With the Research Centre of Hospital Laval and at the University Laval

Measuring waist circumference is key to assessing cardiometabolic risk QUEBEC, Dec. 15 /Xinhua-PRNewswire/ -- Today's issue of Nature (Vol # 444) summarizes in an article, signed by both Professor Jean-Pierre Despres and Doctor Isabelle Lemieux from the University of Laval, the current ...

2006-12-15 11:25 957

Landmark Study of Avastin in Lung Cancer Published Today in New England Journal of Medicine

- Avastin is First Medicine to Extend Survival Beyond One Year in Patients with Previously Untreated Non-Small Cell Lung Cancer BASEL, Switzerland, Dec. 14 /Xinhua-PRNewswire/ -- Avastin is the first medicine proven to help previously untreated patients suffering from the most common ...

2006-12-14 09:38 840

New VaccineS Against Cervical Cancer Major Opportunity for Developing World

LONDON and GENEVA, Dec. 13 /Xinhua-PRNewswire/ -- The introduction of new vaccines against Human Papillomavirus (HPV), the virus that causes cervical cancer, could have a major impact on the health of women in the developing world. More than 250 000 women died from cervical cancer in 2005...

2006-12-13 17:08 932

China Sky One Medical Purchases Competitor Heilongjiang Tianlong Pharmaceutical Company

LOS ANGELES, Calif., Dec. 13 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (OTC Bulletin Board: CSKI), one of the leading producers and distributors for external-Chinese medicines in China, has announced that a strategic agreement was reached between Liu Yan-qing, pres...

2006-12-13 21:30 1077

New Study Shows Clexane(R) / Lovenox(R) (Enoxaparin Sodium Injection) is More Effective Than Unfractionated Heparin (UFH) for Preventing the Risk of Venous Thromboembolism (VTE) in Patients With Acute Ischemic Stroke

- The PREVAIL Study Showed That in Acute Ischemic Stroke Patients Treated With Clexane(R) / Lovenox(R), the Risk of Having a VTE was Lowered by a Significant 43% With no Significant Increase in Clinically Important Bleedings When Compared to UFH ORLANDO,...

2006-12-13 09:47 1092